Skip to content

APLS

Healthcare

☆ Add to watchlist

Updated Oct 17 · 9 feeds behind: FDA drug approvals, 1 day, and 8 more · Every feed →

On this page

The market view

Price chart

The interactive APLS chart (by TradingView) loads here.

Our take

4 rules fired on APLS

In short: none of these rules has solid or some evidence yet, so they show no clear lean on APLS.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

All 4 rules
The 0–100 score for APLS, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on APLS, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Is disclosure activity unusual?

No insider or Congress trades of APLS are on file, so there is no history to compare. Missing records do not mean no one traded.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Public officials

FDA & trials

Owners & lobbying

All 13 records in this snapshot
  1. Record date
  2. Record date
  3. Record date
  4. Record date
  5. Record date
  6. Filed
  7. Filed
    Biogen Inc. ↗

    13D amendment

  8. Filed
  9. Filed
  10. Filed
  11. Filed
  12. Filed
  13. Disclosed
    Donald J Trump · Purchase

    Transaction dated Feb 2, 2026

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on APLS disclosed in the last 90 days.

See every Congress trade on APLS →

Company insiders

No insider buys or sells of APLS filed in the last 90 days.

See every insider trade on APLS →

Filings & events

Company filings (8-K) 43

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Other events · item 8.017
  • Signed a major agreement · item 1.015
  • Directors or officers joined, left or got new pay · item 5.025
  • Quarterly or yearly results · item 2.025
  • Shared information with investors · item 7.013
  • Ended a major agreement · item 1.022

Filing red flags 24

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 17

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

Planned insider sales (Form 144) 144

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

None in the last 90 days · 144 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 7

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 2 filings
  • 13G, just holds: 5 filings

Filed most: Biogen Inc. (2) · State Street Corp (1) · Rtw Investments, LP (1) · BlackRock, Inc. (1)

Biggest named funds (13F)

The largest APLS holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on APLS

  1. ▲ BUYDonald J Trump PresidentAPLS$15K–$50Kdisclosed May 8 · filed 95 days after the trade · late
See the trades on APLS in the feed →
People & votes

Which members of Congress traded APLS, sponsored bills that touch it and voted on them — opens here.